Skip to content

13F-HR filed by Checkpoint Capital L.P.

Checkpoint Capital L.P. filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 10 holding rows worth $298,471,395.

Accession
0001977548-25-000008
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 10 entries on the cover page, a total value of $298,471,395 stated on the cover page (in dollars after the unit check, H1), rows summing to $298,471,395 with VALUE read as dollars as filed, 13F file number 028-23869. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARGENX SE SPONSORED ADR04016X101ADR150,000$110,634,000dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM763,707$77,126,770dollars as filed
CORCEPT THERAPEUTICS INC218352102COM392,331$32,606,629dollars as filed
DISC MEDICINE INC COM254604101Stock430,000$28,414,400dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock492,300$22,990,410dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock260,000$10,829,000dollars as filed
SEPTERNA INC COM81734D104Stock283,158$5,326,202dollars as filed
STOKE THERAPEUTICS INC86150R107COM212,049$4,983,152dollars as filed
KYMERA THERAPEUTICS INC501575104COM61,750$3,495,050dollars as filed
CYTOKINETICS INC23282W605COM NEW37,587$2,065,782dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001977548-25-000008this filing2025-11-14acceptance time not in the bulk data set